Horan Securities, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Horan Securities, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$9,595
-5.6%
2660.0%0.00%
-20.0%
Q1 2023$10,159
-32.9%
2660.0%0.01%
-44.4%
Q4 2022$15,135
+37.6%
2660.0%0.01%
+28.6%
Q3 2022$11,000
-15.4%
2660.0%0.01%
-12.5%
Q2 2022$13,000
+18.2%
2660.0%0.01%
+33.3%
Q1 2022$11,0000.0%2660.0%0.01%
-14.3%
Q4 2021$11,000
-8.3%
2660.0%0.01%
-22.2%
Q2 2021$12,000
+9.1%
2660.0%0.01%0.0%
Q1 2021$11,0000.0%2660.0%0.01%0.0%
Q4 2020$11,000
+57.1%
2660.0%0.01%
+28.6%
Q3 2020$7,0000.0%2660.0%0.01%
-12.5%
Q2 2020$7,000
+40.0%
2660.0%0.01%
+14.3%
Q1 2020$5,000
+25.0%
2660.0%0.01%
+75.0%
Q3 2019$4,000
-20.0%
2660.0%0.00%
-33.3%
Q2 2019$5,000
+25.0%
2660.0%0.01%
+50.0%
Q1 2019$4,0000.0%2660.0%0.00%
-20.0%
Q4 2018$4,0000.0%2660.0%0.01%
+25.0%
Q3 2018$4,000
-20.0%
2660.0%0.00%
-20.0%
Q2 2018$5,0000.0%2660.0%0.01%
+25.0%
Q1 2018$5,0000.0%2660.0%0.00%
-20.0%
Q4 2017$5,0000.0%2660.0%0.01%0.0%
Q3 2017$5,000
+66.7%
2660.0%0.01%
+66.7%
Q2 2017$3,0000.0%2660.0%0.00%0.0%
Q1 2017$3,000
+50.0%
2660.0%0.00%0.0%
Q3 2016$2,0002660.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,506,473$61,283,0005.13%
First Light Asset Management, LLC 1,477,496$60,105,0003.96%
SNYDER CAPITAL MANAGEMENT L P 3,427,476$139,430,0003.69%
DOHENY ASSET MANAGEMENT /CA 80,400$3,271,0002.34%
Redwood Investments, LLC 619,766$25,212,0002.11%
HighMark Wealth Management LLC 53,341$2,170,0001.60%
SILVERARC CAPITAL MANAGEMENT, LLC 60,170$2,448,0001.38%
Third Security, LLC 168,604$6,859,0001.33%
Taylor Wealth Management Partners 87,654$3,566,0001.27%
Penn Capital Management Company, LLC 290,394$11,813,0001.19%
View complete list of HALOZYME THERAPEUTICS INC shareholders